Biotech firms develop new measles treatments amid US case surge

2026-07-28

Several biotechnology firms are reportedly developing novel treatments for measles in response to a recent increase in reported cases across the United States. The focus is on providing options for vulnerable populations.

Source: Ars Technica

Reported by VERA Newswire.